Suministro por exclusividad del fármaco Maralixibat medicamento Livmarli® con destino a las Farmacias Hospitalarias del Área de Salud de Badajoz
TED · 548031-2026Award noticeawardedNo deadline given
Value
Estimated—
Awarded€265,284 · 265,284 EUR
WinnerMirum Pharmaceuticals International, B. V.
Who already wins at this buyer
Firms with recorded awards from Gerencia del Área de Salud de Badajoz in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| JANSSEN-CILAG, S.A. | 1 | €353,000 | 2026-06-01 |
| Mirum Pharmaceuticals International, B. V. | 1 | €265,284 | 2026-06-22 |
| GILEAD SCIENCES, S.L. | 1 | €242,404 | 2026-06-12 |
Full buyer profile: what Gerencia del Área de Salud de Badajoz buys and who wins it →
CPV codes
33600000 Medical equipment & pharmaceuticalsDescription
Medicamento que ayuda a eliminar las sustancias llamadas ácidos biliares del organismo.
Similar tenders
Closest by meaning — across languages, via embeddings.